ARMC
GH icon

American Research & Management Company’s Guardant Health GH Stock Holding History

American Research & Management Company’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Hold
20
– – ﹤0.01% 396
2022
Q2 		$1K Hold
20
– – ﹤0.01% 381
2022
Q1 		$1K Hold
20
– – ﹤0.01% 385
2021
Q4 		$2K Hold
20
– – ﹤0.01% 365
2021
Q3 		$3K Hold
20
– – ﹤0.01% 348
2021
Q2 		$2K Buy
+20
New +$2.69K ﹤0.01% 361

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

American Research & Management Company's GH Position: Q3 2022 in Review

American Research & Management Company held its Guardant Health (GH) position steady in Q3 2022 at 20 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #396.

American Research & Management Company first reported a position in GH in Q2 2021 and has held it in 6 quarters since. The position peaked at $3K in Q3 2021. 328 funds tracked by Wall St. Rank hold GH as of Q3 2022.

  • American Research & Management Company held 20 shares of Guardant Health worth $1K as of Q3 2022.
  • American Research & Management Company left its Guardant Health share count unchanged in Q3 2022.
  • Guardant Health made up ﹤0.01% of American Research & Management Company's portfolio in Q3 2022, its #396 holding.
  • American Research & Management Company first reported a position in Guardant Health in Q2 2021 and has held it in 6 quarters since.
  • American Research & Management Company's Guardant Health position peaked at $3K in Q3 2021.
  • 328 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.